US EditionNew Zealand Bans Puberty Blockers for Trans Youth
New Zealand suspends new puberty blocker prescriptions for gender dysphoria, following a UK clinical trial due in 2031 and citing limited evidence on benefits and risks, Health Minister said.
- On Wednesday, New Zealand Cabinet agreed to halt new prescriptions of puberty blockers for young people with gender dysphoria until the United Kingdom clinical trial results in 2031 are available.
- The Cass Review, led by paediatrician Dr Hilary Cass, concluded the evidence base was 'remarkably weak' and recommended a formal clinical trial, while last year the Ministry of Health released an evidence brief finding limited, poor-quality support.
- The medicines remain available for recognised medical conditions such as early-onset puberty, endometriosis, and prostate cancer, and prescribers may continue off-label use under section 25 of the Medicines Act.
- PATHA criticised the review's expert makeup, with Jennifer Shields saying it excluded trans experts, while Green Party MP Ricardo Menéndez March accused the Government of targeting trans people, and ACT Party spokeswoman Karen Chhour welcomed aligning regulations with the United Kingdom approach.
- Cabinet ordered a review of settings once UK trial results are available, directing the Ministry of Health to follow the United Kingdom NHS and Nordic countries that recently tightened access.
44 Articles
44 Articles
New York Post
New Zealand bans puberty blockers for transgender minors
New Zealand health officials announced Wednesday that new prescriptions for puberty blockers will no longer be issued to children identifying as transgender starting Dec. 19.
Puberty blockers: why politicians overriding doctors sets a dangerous precedent
Darya Komarova/Getty ImagesThe government’s ban on puberty blockers for gender-affirming care marks a troubling shift: politicians are now making decisions that should sit with clinicians working alongside young people and their families or whānau. Puberty blockers have been used in gender-affirming healthcare for decades. They temporarily suppress the hormones that cause pubertal development, giving young people and their families time to make …
New Zealand, world’s top prescriber of puberty blockers to minors, does a 180
by WorldTribune Staff, November 20, 2025 Real World News New Zealand has decided that it will no longer allow puberty blockers to be prescribed to minors. The nation had been the world’s top prescriber of what the woke insists are safe treatments for so-called “gender affirming care.” According to the New Zealand Ministry of Health’s […]
'In loco parentis': When the state says it knows best
Analysis: The Government has put a moratorium on clinicians handing out new prescriptions for puberty blockers to trans youth, overruling personal choice and parental responsibility The post ‘In loco parentis’: When the state says it knows best appeared first on Newsroom.
New Zealand bans puberty blockers for trans youth to 'align approach with UK'
The New Zealand government has announced it is banning puberty blockers for transgender youth as it awaits the results of a major clinical trial in the UK – which are not expected until 2031. The announcement means that, from 19 December, any new prescriptions of hormone suppressing drugs – known as gonadotropin-releasing hormone analogues – for the treatment of gender dysphoria will be halted. However, the drugs will remain available to trans y…
Coverage Details
Bias Distribution
- 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
